Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xeroderma Pigmentosum, Complementation Group D
|
111 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||
Stomach Carcinoma
|
652 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Squamous cell carcinoma of the head and neck
|
348 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Prostate carcinoma
|
1168 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.020 | 1.000 | 2 | 2005 | 2019 | ||||
Primary malignant neoplasm of lung
|
981 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.030 | 1.000 | 3 | 2013 | 2019 | ||||
Primary malignant neoplasm
|
1374 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.070 | 1.000 | 7 | 2005 | 2018 | ||||
Pancreatic carcinoma
|
322 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Neoplasms
|
1644 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.020 | 1.000 | 2 | 2007 | 2010 | ||||
MYELODYSPLASTIC SYNDROME
|
95 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Malignant tumor of colon
|
688 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Malignant Neoplasms
|
1641 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.070 | 1.000 | 7 | 2005 | 2018 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||
Malignant neoplasm of stomach
|
615 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Malignant neoplasm of prostate
|
1082 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.020 | 1.000 | 2 | 2005 | 2019 | ||||
Malignant neoplasm of pancreas
|
277 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Malignant neoplasm of mouth
|
184 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1 | 2010 | 2010 | |||||
Malignant neoplasm of lung
|
1142 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.030 | 1.000 | 3 | 2013 | 2019 | ||||
Malignant neoplasm of esophagus
|
214 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Malignant neoplasm of endometrium
|
197 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.030 | 1.000 | 3 | 2006 | 2014 | ||||
Malignant neoplasm of breast
|
3417 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Malignant Head and Neck Neoplasm
|
118 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.020 | 1.000 | 2 | 2005 | 2018 | ||||
Malignant Glioma
|
22 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Lymphoma, Non-Hodgkin
|
197 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Lymphoma, Follicular
|
83 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.020 | 1.000 | 2 | 2012 | 2014 |